A non-invasive, multi-target approach to treat diabetic retinopathy
Hyperglycemia invoke number of pathways resulting in development of diabetic retinopathy (DR), including protein kinase C activation, increased expression of VEGF, advanced glycation end product (AGEs) formation and activation of polyol pathway, among which the pathophysiology of aldose reductase (A...
Main Authors: | Angeline Julius, Waheeta Hopper |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218346705 |
Similar Items
-
Research progress on the roles of aldose reductase in diabetic retinopathy
by: Hong-Zhe Li, et al.
Published: (2015-07-01) -
The use of dimethylsulfoxide as a solvent in enzyme inhibition studies: the case of aldose reductase
by: Livia Misuri, et al.
Published: (2017-01-01) -
Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications
by: Sravya Jannapureddy, et al.
Published: (2021-03-01) -
Partial purification and study of kinetic enzyme reductase in blood cell decomposition of mice with induced atherosclerosis and inhibitory effect of some isoflavones.
by: Nahida Aljalabe, et al.
Published: (2013-12-01) -
Role of Low Density Lipoprotein Cholesterol in Progression of Diabetic Retinopathy
by: Rahul, et al.
Published: (2018-04-01)